Free Trial
NASDAQ:HSTO

Histogen (HSTO) Stock Price, News & Analysis

$0.22
0.00 (0.00%)
(As of 07/25/2024 ET)
Today's Range
$0.22
$0.22
50-Day Range
$0.17
$0.32
52-Week Range
$0.05
$0.93
Volume
71 shs
Average Volume
862 shs
Market Capitalization
$939,840.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HSTO stock logo

About Histogen Stock (NASDAQ:HSTO)

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

HSTO Stock Price History

HSTO Stock News Headlines

Nvidia insiders dumping shares
All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.
Histogen Files For Voluntary Chapter 11 Bankruptcy Protection
Nvidia insiders dumping shares
All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.
Histogen Inc HSTO
Histogen Board Approves To Dissolve And Wind Down Operations
See More Headlines
Receive HSTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HSTO
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$19,000.00
Book Value
$3.13 per share

Miscellaneous

Free Float
4,131,000
Market Cap
$939,840.00
Optionable
Not Optionable
Beta
1.17
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Ms. Susan A. Knudson (Age 60)
    President, CEO, CFO, COO, Chief Compliance Officer & Corporate Secretary
    Comp: $653.2k

HSTO Stock Analysis - Frequently Asked Questions

How have HSTO shares performed this year?

Histogen's stock was trading at $0.3077 at the beginning of 2024. Since then, HSTO stock has decreased by 28.5% and is now trading at $0.22.
View the best growth stocks for 2024 here
.

How were Histogen's earnings last quarter?

Histogen Inc. (NASDAQ:HSTO) released its earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.20) by $0.40. The firm earned $0.59 million during the quarter.

When did Histogen's stock split?

Histogen's stock reverse split on the morning of Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Histogen?

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Histogen own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Carnival Co. & (CCL), Intel (INTC), Genius Brands International (GNUS), Gilead Sciences (GILD), Clovis Oncology (CLVS), B2Gold (BTG) and BIOLASE (BIOL).

This page (NASDAQ:HSTO) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners